/C O R R E C T I O N -- Covance Inc./

In the news release, "Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2009 Financial Results Conference Call," issued Monday, October 5, 2009 by Covance Inc. over PR Newswire, we are advised by the company that the earnings is expected to be issued after market close on October 21, 2009, rather than October 28, 2009, and the investor conference call will be broadcast live over the Internet on Thursday, October 22, 2009 at 9:00 a.m. ET, rather than Thursday, October 29, 2009 as originally issued inadvertently. The complete, corrected release follows:

Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2009 Financial Results Conference Call

PRINCETON, N.J., Oct. 5 /PRNewswire-FirstCall/ -- In conjunction with its third quarter 2009 earnings release (expected to be issued after market close on October 21, 2009), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference call that will be broadcast live over the Internet on Thursday, October 22, 2009 at 9:00 a.m. ET.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 10,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

*If you are unable to participate during the live webcast, the event will be archived on the web site http://www.covance.com for 14 days.

What: Covance Third Quarter 2009 Earnings Webcast and Slide Presentation When: October 22, 2009, 9:00 a.m. ET* Where: http://www.covance.com

SOURCE Covance Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...